Alvotech ALVO
NASDAQ ALVO
$5.20 +0.01 (+0.29%)
As of: Sep 9, 2026 · 1:27 PM EDT

Alvotech (ALVO) Interest & Investment Income (2021 - 2026)

Alvotech's (ALVO) quarterly Interest & Investment Income came in at -$16.4 million in Q2 2026, down 171.54% on a YoY basis from $22.9 million in Q2 2025, and down 149.11% quarter-over-quarter from $33.4 million in Q1 2026.

Analysis

Alvotech (ALVO) Interest & Investment Income (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Interest & Investment Income for 6 consecutive years, with -$16.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Interest & Investment Income fell 171.54% year-over-year to -$16.4 million; the trailing twelve-month figure through Jun 2026 stood at $187.7 million (up 26.33% YoY), and the FY2025 full-year result was $198.5 million, up 147.67% from the prior year.
  • Interest & Investment Income fell to -$16.4 million in Q2 2026 per ALVO's latest filing, from $33.4 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $149.2 million in Q4 2025 and bottomed at -$41.6 million in Q4 2023.
  • Historically, Interest & Investment Income has averaged $43.2 million across 5 years, with a median of $28.2 million in 2025.
  • The sharpest annual moves came in 2023 and 2025: Interest & Investment Income plunged 181.54% in 2023, then soared 16031.29% in 2025.
  • Over 5 years, Interest & Investment Income stood at $51.0 million in 2022, then slumped by 181.54% to -$41.6 million in 2023, then surged by 102.56% to $1.1 million in 2024, then surged by 13900.66% to $149.2 million in 2025, then slumped by 111.0% to -$16.4 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered -$16.4 million, $33.4 million, and $149.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Teva Pharmaceutical Industries 42.74 Bn 39.09 Bn 2.15 Bn -
2 Viatris 19.12 Bn 18.23 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn 31.57 Mn
4 Amneal Pharmaceuticals 5.47 Bn 5.35 Bn 334.51 Mn -55.04 Mn
5 Bausch Health Companies 2.37 Bn 530.13 Mn 2.10 Bn 11.00 Mn
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn -16.41 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -3.64 Mn
8 Amphastar Pharmaceuticals 991.81 Mn 701.69 Mn 93.47 Mn 2.29 Mn
9 Fennec Pharmaceuticals 412.12 Mn 370.87 Mn 17.15 Mn 287,000.00
10 RedHill Biopharma 182.76 Mn 182.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.41 Mn
Mar 31, 2026 33.41 Mn
Dec 31, 2025 149.25 Mn
Sep 30, 2025 21.44 Mn
Jun 30, 2025 22.94 Mn
Mar 31, 2025 126.31 Mn
Dec 31, 2024 1.07 Mn
Sep 30, 2024 -1.74 Mn
Jun 30, 2024 80.04 Mn
Mar 31, 2024 783,000.00
Dec 31, 2023 -41.56 Mn
Aug 31, 2023 122.48 Mn
Jun 30, 2023 121.25 Mn
Mar 20, 2023 4.82 Mn
Dec 31, 2022 50.97 Mn
Aug 31, 2022 50.97 Mn
Jun 30, 2022 48.42 Mn
Mar 20, 2022 2.55 Mn
Dec 31, 2021 51.56 Mn
Sep 30, 2021 3,000.00